In vitro haemocompatibility of a novel bioprosthetic total artificial heart

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 6, 2012, Pages

  Jansen, Piet ^a   van Oeveren, Willem ^b   Capel, Antoine ^a   Carpentier, Alain ^c  

^a Carmat   (France)

^b HaemoScan BV   (Netherlands)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Artificial heart; Assisted circulation; Haemocompatibility; Transplantation

Indexed keywords

ANTITHROMBIN III; FIBRINOGEN; HEPARIN; POLITEF; POLYVINYLCHLORIDE; SILICONE; THROMBIN; THROMBOXANE B2; BIOMATERIAL; SILICONE DERIVATIVE;

ARTICLE; BIOCOMPATIBILITY; BLOOD COMPATIBILITY; BLOOD SAMPLING; CONTROLLED STUDY; ERYTHROCYTE; FIBRINOGEN BLOOD LEVEL; HEART VALVE BIOPROSTHESIS; HUMAN; IN VITRO STUDY; MATERIAL COATING; PERICARDIUM; PRIORITY JOURNAL; PULSATILE FLOW; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ADHESION; THROMBOCYTE COUNT; ARTIFICIAL HEART PACEMAKER; BIOPROSTHESIS; MATERIALS TESTING; METHODOLOGY; PROSTHESIS; SURFACE PROPERTY; TRANSPLANTATION; ULTRASTRUCTURE;

BIOPROSTHESIS; BLOOD SPECIMEN COLLECTION; COATED MATERIALS, BIOCOMPATIBLE; HEART, ARTIFICIAL; HEPARIN; HUMANS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; PERICARDIUM; POLYTETRAFLUOROETHYLENE; PROSTHESIS DESIGN; PULSATILE FLOW; SILICONES; SURFACE PROPERTIES;

EID: 84865371303     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs187     Document Type: Article

References (20)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123:e18-209.
2. Tendera M. Epidemiology, treatment, and guidelines for the treatment of heart failure in Europe. Eur Heart J Suppl 2005;7:J5-9.
3. Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC Jr et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation 2007;115:1563-70.
4. Miller LW. Left ventricular assist devices are underutilized. Circulation 2011;123:1552-8.
5. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh Official Adult Heart Transplant Report-2010. J Heart Lung Transplant 2010;29:1089-103.
6. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.
7. Baldwin JT, Mann DL. NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT Pilot Trial. J Cardiac Failure 2010; 16:855-8.
8. Cleveland JC, Naftel DC, Reece TB, Murray M, Antaki J, Pagani FD et al. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database. J Heart Lung Transplant 2011;30:862-9.
9. Farrar DJ, Hill JD, Pennington DG, McBride LR, Holman WL, Kormos RL et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1997;113:202-9.
10. Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 2004;351:859-67.
11. Roussel JC, Senage T, Baron O, Perigaud C, Habash O, Rigal JC et al. CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients. Ann Thorac Surg 2009;87:124-30.
12. Carpentier A, Dubost C. From xenograft to bioprothesis: evolution of concepts and techniques. In: Ionescu MI, Ross DN, Wooler GH (eds). Biological Tissue in Heart Valve Replacement. London: Butterworths, 1972, Vol. 23, 515-42.
13. Mussivand T, Hetzer R, Vitali E, Meyns B, Noirhomme P, Koerfer R et al. Clinical results with an ePTFE inflow conduit for mechanical circulatory support. J Heart Lung Transplant 2004;23:1366-70.
14. Marchand MA, Aupart MR, Norton R, Goldsmith IRA, Pelletier LC, Pellerin M et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg 2001; 71:S236-9.
15. Yoshizaki T, Tabuchi N, van Oeveren W, Shibamiya A, Koyama T, Sunamori M. PMEA polymer-coated PVC tubing maintains anti-thrombogenic properties during in vitro whole blood circulation. Int J Artif Organs 2005;28: 834-40.
16. Rubens FD, Mesana T. The inflammatory response to cardiopulmonary bypass: a therapeutic overview. Perfusion 2004;19:5-12.
17. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005;79: 1072-80.
18. Fink H, Hong J, Drotz K, Risberg B, Sanchez J, Sellborn A. An in vitro study of blood compatibility of vascular grafts made of bacterial cellulose in comparison with conventionally-used graft materials. J Biomed Mater Res A 2011;97:52-8.
19. Seyfert UT, Biehl V, Schenk J. In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4. Biomol Eng 2002;19:91-6.
20. Carpentier A. Lasker Clinical Research Award: the surprising rise of nonthrombogenic valvular surgery. Nat Med 2007;13:1165-8.